Cellectis S.A.
CMVLF
$3.47
$0.3912.66%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.78M | 10.40M | 35.17M | 16.73M | 10.66M |
| Total Other Revenue | 1.77M | 1.81M | 1.99M | 1.47M | 1.37M |
| Total Revenue | 7.55M | 12.21M | 37.16M | 18.19M | 12.03M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 7.55M | 12.21M | 37.16M | 18.19M | 12.03M |
| SG&A Expenses | 5.59M | 4.80M | 5.21M | 5.08M | 4.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -63.00K | 320.00K | -154.00K | -378.00K | -426.00K |
| Total Operating Expenses | 32.72M | 29.56M | 29.12M | 27.78M | 26.21M |
| Operating Income | -25.17M | -17.35M | 8.04M | -9.59M | -14.18M |
| Income Before Tax | -17.72M | -26.74M | 589.00K | -23.74M | -18.13M |
| Income Tax Expenses | 46.00K | -423.00K | -- | -- | -- |
| Earnings from Continuing Operations | -17.77M | -26.32M | 589.00K | -23.74M | -18.13M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.77M | -26.32M | 589.00K | -23.74M | -18.13M |
| EBIT | -25.17M | -17.35M | 8.04M | -9.59M | -14.18M |
| EBITDA | -22.13M | -15.33M | 11.17M | -6.46M | -11.13M |
| EPS Basic | -0.18 | -0.26 | 0.01 | -0.24 | -0.18 |
| Normalized Basic EPS | -0.11 | -0.17 | 0.00 | -0.15 | -0.11 |
| EPS Diluted | -0.18 | -0.26 | 0.01 | -0.24 | -0.18 |
| Normalized Diluted EPS | -0.11 | -0.17 | 0.00 | -0.15 | -0.11 |
| Average Basic Shares Outstanding | 100.53M | 100.33M | 100.33M | 98.90M | 100.16M |
| Average Diluted Shares Outstanding | 100.53M | 100.33M | 101.71M | 98.90M | 100.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |